|
1
|
Chung SW, Chen YH, Yet SF, Layne MD and
Perrella MA: Endotoxin-induced down-regulation of Elk-3 facilitates
heme oxygenase-1 induction in macrophages. J Immunol.
176:2414–2420. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Da Sacco L, Baldassarre A and Masotti A:
Bioinformatics tools and novel challenges in long non-coding RNAs
(lncRNAs) functional analysis. Int J Mol Sci. 13:97–114. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hanahan D and Weinberg RA: The hallmarks
of cancer. Cell. 100:57–70. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Schroeder JA, Adriance MC, Thompson MC,
Camenisch TD and Gendler SJ: MUC1 alters beta-catenin-dependent
tumor formation and promotes cellular invasion. Oncogene.
22:1324–1332. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhao Y, Jian W, Gao W, Zheng YX, Wang YK,
Zhou ZQ, Zhang H and Wang CJ: RNAi silencing of c-Myc inhibits cell
migration, invasion, and proliferation in HepG2 human
hepatocellular carcinoma cell line: c-Myc silencing in
hepatocellular carcinoma cell. Cancer Cell Int. 13:232013.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sahu A, Singhal U and Chinnaiyan AM: Long
noncoding RNAs in cancer: From function to translation. Trends
Cancer. 1:93–109. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bhan A and Mandal SS: lncRNA HOTAIR: A
master regulator of chromatin dynamics and cancer. Biochim Biophys
Acta. 1856:151–164. 2015.PubMed/NCBI
|
|
8
|
Yuan JH, Yang F, Wang F, Ma JZ, Guo YJ,
Tao QF, Liu F, Pan W, Wang TT, Zhou CC, et al: A long noncoding RNA
activated by TGF-β promotes the invasion-metastasis cascade in
hepatocellular carcinoma. Cancer Cell. 25:666–681. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Xing Z, Lin A, Li C, Liang K, Wang S, Liu
Y, Park PK, Qin L, Wei Y, Hawke DH, et al: lncRNA directs
cooperative epigenetic regulation downstream of chemokine signals.
Cell. 159:1110–1125. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Gutschner T, Hämmerle M, Eissmann M, Hsu
J, Kim Y, Hung G, Revenko A, Arun G, Stentrup M, Gross M, et al:
The noncoding RNA MALAT1 is a critical regulator of the metastasis
phenotype of lung cancer cells. Cancer Res. 73:1180–1189. 2013.
View Article : Google Scholar
|
|
11
|
Zhao Y, Yang Y, Trovik J, Sun K, Zhou L,
Jiang P, Lau TS, Hoivik EA, Salvesen HB, Sun H, et al: A novel wnt
regulatory axis in endometrioid endometrial cancer. Cancer Res.
74:5103–5117. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Shen Y, Ma J, Yan R, Ling H, Li X, Yang W,
Gao J, Huang C, Bu Y, Cao Y, et al: Impaired self-renewal and
increased colitis and dysplastic lesions in colonic mucosa of
AKR1B8-deficient mice. Clin Cancer Res. 21:1466–1476. 2015.
View Article : Google Scholar
|
|
13
|
Cao D, Fan ST and Chung SS: Identification
and characterization of a novel human aldose reductase-like gene. J
Biol Chem. 273:11429–11435. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu Z, Yan R, Al-Salman A, Shen Y, Bu Y,
Ma J, Luo DX, Huang C, Jiang Y, Wilber A, et al: Epidermal growth
factor induces tumour marker AKR1B10 expression through activator
protein-1 signalling in hepatocellular carcinoma cells. Biochem J.
442:273–282. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bu Y, Li X, He Y, Huang C, Shen Y, Cao Y,
Huang D, Cai C, Wang Y, Wang Z, et al: A phosphomimetic mutant of
RelA/p65 at Ser536 induces apoptosis and senescence: An implication
for tumor-suppressive role of Ser536 phosphorylation. Int J Cancer.
138:1186–1198. 2016. View Article : Google Scholar
|
|
16
|
Ma J, Yan R, Zu X, Cheng JM, Rao K, Liao
DF and Cao D: Aldo-keto reductase family 1 B10 affects fatty acid
synthesis by regulating the stability of acetyl-CoA
carboxylase-alpha in breast cancer cells. J Biol Chem.
283:3418–3423. 2008. View Article : Google Scholar
|
|
17
|
Liu Z, Zhong L, Krishack PA, Robbins S,
Cao JX, Zhao Y, Chung S and Cao D: Structure and promoter
characterization of aldo-keto reductase family 1 B10 gene. Gene.
437:39–44. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Huang C, Verhulst S, Shen Y, Bu Y, Cao Y,
He Y, Wang Y, Huang D, Cai C, Rao K, et al: AKR1B10 promotes breast
cancer metastasis through integrin α5/δ-catenin mediated
FAK/Src/Rac1 signaling pathway. Oncotarget. 7:43779–43791.
2016.PubMed/NCBI
|
|
19
|
Yan R, Zu X, Ma J, Liu Z, Adeyanju M and
Cao D: Aldo-keto reductase family 1 B10 gene silencing results in
growth inhibition of colorectal cancer cells: Implication for
cancer intervention. Int J Cancer. 121:2301–2306. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Harris SL and Levine AJ: The p53 pathway:
Positive and negative feedback loops. Oncogene. 24:2899–2908. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Issaeva N, Bozko P, Enge M, Protopopova M,
Verhoef LG, Masucci M, Pramanik A and Selivanova G: Small molecule
RITA binds to p53, blocks p53-HDM-2 interaction and activates p53
function in tumors. Nat Med. 10:1321–1328. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tetsu O and McCormick F: Beta-catenin
regulates expression of cyclin D1 in colon carcinoma cells. Nature.
398:422–426. 1999. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
Gartel AL, Ye X, Goufman E, Shianov P, Hay
N, Najmabadi F and Tyner AL: Myc represses the p21(WAF1/CIP1)
promoter and interacts with Sp1/Sp3. Proc Natl Acad Sci USA.
98:4510–4515. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Gibb EA, Brown CJ and Lam WL: The
functional role of long non-coding RNA in human carcinomas. Mol
Cancer. 10:382011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Harris CC: Structure and function of the
p53 tumor suppressor gene: Clues for rational cancer therapeutic
strategies. J Natl Cancer Inst. 88:1442–1455. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Riley T, Sontag E, Chen P and Levine A:
Transcriptional control of human p53-regulated genes. Nat Rev Mol
Cell Biol. 9:402–412. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Cao Z, Ma J, Chen X, Zhou B, Cai C, Huang
D, Zhang X and Cao D: Uridine homeostatic disorder leads to DNA
damage and tumorigenesis. Cancer Lett. 372:219–225. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Schmitz AA, Govek EE, Böttner B and Van
Aelst L: Rho GTPases: Signaling, migration, and invasion. Exp Cell
Res. 261:1–12. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Prensner JR and Chinnaiyan AM: The
emergence of lncRNAs in cancer biology. Cancer Discov. 1:391–407.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kim YG, Kim MJ, Lim JS, Lee MS, Kim JS and
Yoo YD: ICAM-3-induced cancer cell proliferation through the
PI3K/Akt pathway. Cancer Lett. 239:103–110. 2006. View Article : Google Scholar
|
|
31
|
Li X, Xu Y, Chen Y, Chen S, Jia X, Sun T,
Liu Y, Li X, Xiang R and Li N: SOX2 promotes tumor metastasis by
stimulating epithelial-to-mesenchymal transition via regulation of
WNT/β-catenin signal network. Cancer Lett. 336:379–389. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Valenta T, Hausmann G and Basler K: The
many faces and functions of β-catenin. EMBO J. 31:2714–2736. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Nakamura T, Hamada F, Ishidate T, Anai K,
Kawahara K, Toyoshima K and Akiyama T: Axin, an inhibitor of the
Wnt signalling pathway, interacts with beta-catenin, GSK-3beta and
APC and reduces the beta-catenin level. Genes Cells. 3:395–403.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Luo J: Glycogen synthase kinase 3beta
(GSK3beta) in tumorigenesis and cancer chemotherapy. Cancer Lett.
273:194–200. 2009. View Article : Google Scholar
|
|
35
|
Minde DP, Anvarian Z, Rüdiger SG and
Maurice MM: Messing up disorder: How do missense mutations in the
tumor suppressor protein APC lead to cancer? Mol Cancer.
10:1012011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Kolligs FT, Bommer G and Göke B:
Wnt/beta-catenin/tcf signaling: A critical pathway in
gastrointestinal tumorigenesis. Digestion. 66:131–144. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
MacDonald BT, Tamai K and He X:
Wnt/beta-catenin signaling: Components, mechanisms, and diseases.
Dev Cell. 17:9–26. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Li YJ, Wei ZM, Meng YX and Ji XR:
Beta-catenin up-regulates the expression of cyclinD1, c-myc and
MMP-7 in human pancreatic cancer: Relationships with carcinogenesis
and metastasis. World J Gastroenterol. 11:2117–2123. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Fang D, Hawke D, Zheng Y, Xia Y,
Meisenhelder J, Nika H, Mills GB, Kobayashi R, Hunter T and Lu Z:
Phosphorylation of beta-catenin by AKT promotes beta-catenin
transcriptional activity. J Biol Chem. 282:11221–11229. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Niculescu AB III, Chen X, Smeets M, Hengst
L, Prives C and Reed SI: Effects of p21(Cip1/Waf1) at both the G1/S
and the G2/M cell cycle transitions: pRb is a critical determinant
in blocking DNA replication and in preventing endoreduplication.
Mol Cell Biol. 18:629–643. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Bunz F, Dutriaux A, Lengauer C, Waldman T,
Zhou S, Brown JP, Sedivy JM, Kinzler KW and Vogelstein B:
Requirement for p53 and p21 to sustain G2 arrest after DNA damage.
Science. 282:1497–1501. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Chan TA, Hwang PM, Hermeking H, Kinzler KW
and Vogelstein B: Cooperative effects of genes controlling the
G(2)/M checkpoint. Genes Dev. 14:1584–1588. 2000.PubMed/NCBI
|
